. . . . . . . . . . . "a(CHEBI:pioglitazone) -| r(HGNC:NOS2)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Administration of rosiglitazone or pioglitazone (30 mg/kg, p.o.) significantly inhibited the adjuvant-induced increase in formation of nitrotyrosine and expression of iNOS on both ankle and temporomandibular joints." . . "Selventa" . . . . "2014-07-03T14:31:51.914+02:00"^^ . . .